- 人淋巴細(xì)胞共 55164 條
ND13957肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13957肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14123肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14123肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
GM21295肯尼亞金亞瓦的馬賽 B 淋巴細(xì)胞拼箱Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
GM21295肯尼亞金亞瓦的馬賽 B 淋巴細(xì)胞拼箱Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
GM21318肯尼亞金亞瓦的馬賽 B 淋巴細(xì)胞拼箱Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
GM21318肯尼亞金亞瓦的馬賽 B 淋巴細(xì)胞拼箱Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND11542肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND11542肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13833肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13833肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13948帕金森病 | PD |帕金森病專家小組：來自北美的白人 B淋巴細(xì)胞LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13948帕金森病 | PD |帕金森病專家小組：來自北美的白人 B淋巴細(xì)胞LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13959肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13959肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14031肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14031肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14032人口/便利性控制|控制|神經(jīng)系統(tǒng)正常的白人控制面板 B淋巴細(xì)胞LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14032人口/便利性控制|控制|神經(jīng)系統(tǒng)正常的白人控制面板 B淋巴細(xì)胞LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14044帕金森病 | PD B-淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14044帕金森病 | PD B-淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14177肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14177肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14178進(jìn)行性肌萎縮 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14178進(jìn)行性肌萎縮 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14180進(jìn)行性延髓麻痹 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND14180進(jìn)行性延髓麻痹 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
GM21298肯尼亞金亞瓦的馬賽 B 淋巴細(xì)胞拼箱Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
GM21298肯尼亞金亞瓦的馬賽 B 淋巴細(xì)胞拼箱Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
GM21300肯尼亞金亞瓦的馬賽 B 淋巴細(xì)胞拼箱Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
GM21300肯尼亞金亞瓦的馬賽 B 淋巴細(xì)胞拼箱Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
GM21301肯尼亞金亞瓦的馬賽 B 淋巴細(xì)胞拼箱Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
GM21301肯尼亞金亞瓦的馬賽 B 淋巴細(xì)胞拼箱Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND09603肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND09603肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13785肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13785肌萎縮側(cè)索硬化癥 1； ALS1 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13958人口/便利控制 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
ND13958人口/便利控制 B 淋巴細(xì)胞 LCL Cell Line細(xì)胞株-BioVector NTCC細(xì)胞庫
- 快速發(fā)布求購信息
